IRCT201303036923N2Completed未知
Comparison the effect of Piracetam versus placebo on control of attention deficit-hyper activity disorder symptoms in Iranian children and adolescents, a double blind randomized clinical trial
Vice chancellor for Research Tehran University of Medical Sciences0 sites36 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 36
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 6 years to 16 years (—)
- Sex
- All
Inclusion Criteria
- •Age 6-16; Diagnosis of ADHD for the first time
- •Exclusion criteria : IQ<70 ; Having other chronic medical illnesses; Be under other medications; Any serious or sever complication during study; Refusal of child or parent to continue the study
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 3
Effect of piracetam in preventing delirium in ICU patientsDelirium.Delirium due to known physiological conditionIRCT20240105060618N1Tehran University of Medical Sciences80
Completed
Phase 2
Clinical Efficacy of Piracetam on the Treatment of Breath _Holding SpellsBreath-holding spells.Other and unspecified abnormalities of breathingIRCT138801231808N1Mazandaran University of Medical Sciences and Health Services50
Not yet recruiting
Phase 2
Comparison of the efficacy of Piracetam and probiotic-Piracetam in cyanotic breath holding spells in childreIRCT20201028049175N8Arak University of Medical Sciences58
Recruiting
Phase 2
Effect of levetiracetam versus placebo on the clinical signs of in bipolar patients in the manic episodeIRCT20120215009014N293Hamedan University of Medical Sciences72
Completed
Phase 3
The Comparison of Levetiracetam and Piracetam efficacy on severe Breath Holding SpellsIRCT20190208042654N1Esfahan University of Medical Sciences64